Menu
Back to Journals » Drug Design, Development and Therapy » Volume 10
Original Research
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,462 | Dovepress* | 11,271+ | 1,552 | 12,823 | |
| PubMed Central* | 2,191 | 747 | 2,938 | ||
| Totals | 13,462 | 2,299 | 15,761 | ||
| *Since 16 August 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 1 | 4 |
View citations on PubMed Central and Google Scholar